Shandong Lutai Huanzhong Pharmaceutical Co. Ltd.

The main purpose of the study is to use Lumiperone Tosylate Capsules produced by Rongchang Pharmaceutical (Zibo) Co., Ltd. as the test preparation and Lumiperone Tosylate Capsules (trade name: Caplyta®) certified by Intra-Cellular Therapies Inc. as the reference preparation to evaluate the bioequivalence of the two preparations in humans through a single-center, randomized, open, single-dose, four-cycle, completely repeated crossover clinical study. Secondary purpose of the study: To observe the safety of the test preparation and the reference preparation in healthy adult subjects in China.